An expert panel of India's central drug authority has recommended permission for conducting a phase-3 clinical trial of single-dose COVID-19 vaccine 'Sputnik Light' as a booster dose, official sources said on Saturday.
The recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. The DCGI had on February바카라 웹사이트4 granted emergency use permission to Sputnik Light vaccine in India, subject to certain regulatory provisions.
Hyderabad-based Dr Reddy's Laboratories had presented its proposal to DCGI for conducting바카라 웹사이트the phase-3 trial of Sputnik바카라 웹사이트Light vaccine as a booster dose. Sputnik Light바카라 웹사이트is the same as component-1 of바카라 웹사이트Sputnik바카라 웹사이트V.바카라 웹사이트
"The바카라 웹사이트Subject바카라 웹사이트Expert바카라 웹사이트Committee바카라 웹사이트(SEC) on COVID-19 of the CDSCO, which reviewed the application on Friday after detailed deliberation, recommended granting permission for the phase-3 clinical trial with the condition바카라 웹사이트to initiate the trial with Sputnik Light vaccine for which the firm is holding emergency use authorisation permission in the country subject to certain regulatory provisions,"바카라 웹사이트바카라 웹사이트an official source said. Sputnik바카라 웹사이트Light바카라 웹사이트vaccine is approved in 29 countries, including Argentina and Russia.
With PTI inputs.
